By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Peter Attia MD#99 – Peter Hotez, M.D., Ph.D.: Continuing the conversation on COVID-19
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
CHAPTERS
- 0:11 – 5:25
Intro and Reaction to the First Episode
Peter Attia explains the timing of this March 19 recording and how quickly things are changing. He and Peter Hotez then discuss the strong response to their first conversation and the appetite for non-dumbed-down science communication.
- •Recorded March 19, and Attia notes podcasts become obsolete quickly in this outbreak
- •Attia plans shorter, more frequent episodes and a dedicated COVID page on his site
- •Hotez says the response came from people in all walks of life
- •Both reject the need for dumbed-down sound bites
- 5:25 – 9:40
True Case Counts and the Threat to Healthcare Workers
Attia asks how far confirmed US cases understate true infections. Hotez says testing is catching up, hospitals are already feeling overwhelmed, and he describes his "lights out" warning about healthcare professionals getting sick.
- •Rising daily counts partly reflect testing finally catching up
- •Hotez is skeptical of the assumptions behind multipliers of 20 to 50 times
- •Hospitals around the country report feeling overwhelmed early on
- •Hotez used provocative language like "angel of death" and "lights out" to get attention
- 9:40 – 12:29
Regional Hot Spots and the Case Multiplier
Attia shares his team's conservative multiplier of about 25 and asks whether 125,000 infections would be a good sign. Hotez explains that cases are clustered in local nodes, such as New York, that will grow and may coalesce.
- •Attia's internal model estimates a multiplier near 25, based on time to death and infectious fatality rate
- •National averages mislead because infections are concentrated geographically
- •Hotez describes growing red blobs on a US map that may coalesce
- •Governor Cuomo's alarm points to New York-like situations elsewhere
- 12:29 – 15:33
Testing Missteps and the Need for a Later Review
Attia asks why the CDC and FDA chose the Roche kit over Chinese tests. Hotez says he doesn't know how decisions were made, argues they should have used commercial kits, and calls for an independent review once the crisis passes.
- •Hotez says commercial kits should have been used from the start
- •He wants an independent committee later to find fixes, not to punish
- •Officials had at least a month or two of warning
- •The testing phase is being fixed while health systems are already stressed
- 15:33 – 22:22
Where the Healthcare System Breaks First
Asked about the rate-limiting step, Hotez says the first breakdown is trust among exhausted doctors and nurses, worsened by reports of severe illness in young adults. They discuss how to add staff, and Hotez floats expanding the Public Health Service or using the military.
- •Hotez sees a breakdown of trust as the first failure, ahead of ventilators and PPE
- •Colleagues getting sick and inconsistent plans fuel the demoralization
- •Moving physicians from other regions is hard because they are underserved and already stretched
- •Hotez floats expanding the Public Health Service or using military medic-style training
- 22:22 – 27:06
Antibody Prophylaxis and the Blood Type Study
Attia asks how people who are not infected can lower their risk. Hotez emphasizes protecting healthcare workers and describes using convalescent antibodies as prophylaxis, then they briefly discuss a study linking ABO blood type to susceptibility.
- •Data on transmission via surfaces is limited, and Hotez prioritizes protecting those near sick people
- •The CDC loosened exposure criteria to keep workers on the job
- •A small antibody dose could protect responders for about two weeks
- •Academic blood bank networks have not been contacted by the federal government
- •Hotez is unsure how the blood type finding applies
- 27:06 – 31:11
Young Patients, ICU Admissions and Long-Term Effects
The two discuss the surprising share of young adults hospitalized in the US and Italy compared with China. They consider smoking, vaping, genetics and mutation as possible explanations, and note heart injury and long-term effects seen after SARS.
- •About half of US hospitalizations are under 54, and roughly a third are aged 20 to 44
- •Hotez raises smoking, vaping and host genetics as possibilities
- •Attia reads ages from a London ICU list and cites a 10-year SARS follow-up showing cardiac and pulmonary disease
- •Hotez notes frequent acute heart injury in Chinese reports and is suspicious of quick mutation claims
- 31:11 – 34:18
Immunity, the 18-Month Projection and Vaccine Timelines
Attia asks whether recovery gives lasting immunity. Hotez cites primate data, discusses the federal 18-month projection, and cautions that a vaccine is likely much further away than that.
- •A primate preprint suggests infection confers immunity, though it may not apply to humans
- •The 18-month figure may come from models of summer decline and fall return
- •Hotez says a vaccine will likely take much longer than eighteen months
- •He is more optimistic about antibody therapy and repurposed drugs
- 34:18 – 38:51
Repurposed Drugs: Kaletra, Hydroxychloroquine, ARBs and Camostat
The conversation turns to treatments. They discuss the Kaletra study, hydroxychloroquine, mixed evidence on ACE2-related blood pressure drugs, and camostat and furin as possible targets.
- •Attia reads the Kaletra paper as showing little benefit in people near death
- •Hotez calls hydroxychloroquine promising but says claims of a cure are overhyped
- •ARB evidence is mixed, with debate over upregulating ACE2 versus anti-inflammatory effects
- •Camostat and the furin protease are discussed as potential targets
- 38:51 – 41:59
Universal Coronavirus Vaccines and Hospital Transmission
Attia notes the similarity between SARS-CoV-1 and CoV-2, and Hotez discusses a universal SARS vaccine and the repeated emergence of coronaviruses. He stresses that coronaviruses tear through hospitals and that protecting healthcare providers should be a national priority.
- •A SARS1 vaccine might be repurposed, raising the question of a universal SARS vaccine
- •This is the third coronavirus pandemic of the century, per Hotez
- •Coronaviruses spread heavily in hospitals, as with SARS1 and MERS
- •Hotez suggests a White House task force on protecting frontline providers
- 41:59 – 45:58
Bioweapon Theory and Why the Virus Is So Dangerous
Attia asks about the idea that the virus was engineered. Hotez says natural bat coronaviruses make that unnecessary, and explains how its mix of lethality, transmissibility and asymptomatic spread makes it so troublesome.
- •Hotez says the plausibility rises slightly with young victims but not by much
- •SARS-like viruses in bats were already well known
- •Attia doubts engineers could design such a virus given limited GMO success
- •Asymptomatic spread and higher transmissibility than SARS-1 make it toxic
- 45:58 – 49:02
Mail, Packages and Food Safety
Attia asks what to do about packages, mail and food. Hotez thinks surface risk is low and close contact is the main route, while Attia cites WHO temperature data and worries more about produce.
- •Hotez says there's little data and he isn't doing anything special about mail
- •Wiping packages with disinfectant wipes is harmless if you want to
- •Attia cites SARS-CoV-1 data suggesting about 56°C for 15 minutes kills the virus
- •Close personal contact remains the most likely transmission route
- 49:02 – 55:42
Mental Health Toll of Isolation
Hotez voices concern about psychological harm from prolonged isolation, including suicide risk and stress on families with special needs members. Both share their own irritability and stress, and Hotez proposes low-cost mental health networks.
- •Hotez is nearly as worried about mental health as about the virus
- •He suggests a low-cost network of mental health counselors, perhaps via academic health centers
- •Attia describes isolation-related irritability
- •Hotez describes sleep loss and stress from vaccine work and media appearances
- 55:42 – 1:06:26
Reasons for Optimism and Closing
Attia asks what Hotez is optimistic about. He cites higher esteem for scientists, faster science communication, appreciation for healthcare workers, and Cuomo's call for the Army Corps of Engineers, before the two wrap up and Attia gives the membership outro.
- •Scientists like Fauci are held in higher esteem
- •Preprint servers and fast journal publication are changing science publishing
- •Public appreciation for physicians and nurses may grow
- •Hotez praises Cuomo and several federal officials
- •Hotez warns that today's statements may look outdated within days
